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013; revised manuscript received December 17,99th percentile of a healthy reference population are
frequently observed in patients with stable coronary artery
disease, elderly subjects, and patients with various chronic
diseases such as type 2 diabetes (1–4). Some have suggested
that a higher decision limit (3-fold the 99th percentile limit)
might be advisable for diagnosing AMI in these patient
groups (3,5).
Regardless of the cutoff value used, the critical tool for
discriminating between AMI-induced cTn release and rela-
tively stable cTn elevations in chronic diseases is serial testing
and the assessment of kinetic changes in cTn. Guidelines
advocate a rise and/or fall of cTn in patients with evidence of
myocardial ischemia, with at least 1 cTn value exceeding the
99th percentile of the reference population (6). It should be
recognized, however, that there is no perfect diagnostic
threshold, and the application of any change criteria thus far is
a trade-off, directed by the need for a high sensitivity or a high
speciﬁcity. Therefore, a profound understanding of the
naturally occurring biological variation of cTn is essential
when interpreting dynamic changes in serial testing. By
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CI = conﬁdence interval
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JACC Vol. 63, No. 17, 2014 Klinkenberg et al.
May 6, 2014:1788–95 Diurnal Rhythm of Cardiac Troponin T
1789deﬁnition, biological variation is measured by serially sam-
pling healthy subjects at regular intervals (7). Thus far, studies
in healthy subjects have reported short-term (hourly) bio-
logical variation of cTn ranging from 3% to 48%, which
translates into reference change values (RCVs) of 45% to 85%
(8–11). This ﬁnding means that a difference in serial cTn
measurements which exceeds this threshold is unlikely due to
analytical and biological variation only and is therefore
considered a “true” change at a p value <0.05. However, it
should be noted that healthy subjects may not be truly
representative of the typical patient who requires clinical
evaluation for chest pain.
The present study comprised a highly standardized
assessment of within-day, diurnal, and between-week bio-
logical variation of cardiac troponin T (cTnT) levels in
subjects with increased odds of requiring hospital examina-
tion for chest pain.
Methods
To examine within-day, diurnal, and between-week varia-
tion in cTnT levels, 2 distinct studies were conducted. Both
studies complied with the principles of the Declaration of
Helsinki and were approved by the institutional review
board and the ethics committee at Maastricht University
Medical Center. All participants provided written informed
consent.
Study 1: within-day and between-week variation. The
study group consisted of 23 male subjects (body mass index
[BMI] 30  4 kg/m2; mean age 63  7 years) who were
diagnosed with type 2 diabetes for a mean duration of 7  5
years (Online Table 1). According to their BMI, 16 subjects
were classiﬁed as overweight (BMI 25 to 30 kg/m2) and 7
subjects as obese (>30 kg/m2). Subjects were recruited by
using advertisements in the local newspaper. Exclusion
criteria were self-reported renal failure, liver disease, morbid
obesity (BMI >40 kg/m2), history of severe cardiovascular
problems (AMI or stroke in the past year), hypertension
(>160 mm Hg systolic blood pressure and/or >100 mm Hg
diastolic blood pressure), and exogenous insulin therapy.
This study is part of a more extensive project investigating
glycemic control and lifestyle interventions (12).
Participants visited the laboratory by car or public trans-
portation on 3 occasions (experiments A to C) in randomized
order (Fig. 1). Subjects were asked to refrain from exhaustive
physical labor and exercise training for 2 days before each test
day. Experiment A estimated within-day cTnT variation
under sedentary conditions. From 8:30 AM until 7:30 PM,
subjects were restricted to a sedentary laboratory environment
and spent the day seated in a chair or couch, while reading,
talking, watching television, or working on a laptop. Partic-
ipants received standardized breakfast, lunch, and dinner at
8:30 AM, 12:30 PM, and 5:00 PM. Blood samples (8 ml) were
collected from an antecubital venous catheter 5 min before
each meal, as well as 90 and 150 min after each meal,
resulting in a total of 9 blood samples collected within 11 h.Experiment B was conducted
to investigate whether within-day
cTnT variation was affected by
light physical activity. The test day
was identical to experiment A,
except for the addition of 15 min
of slow-paced walking (total dis-
tance 800 to 1,000 m, including
2 staircases) after each meal
(at 9:15 AM, 1:15 PM, and 5:45 PM)
to mimic a day with low-to-
moderate levels of physical activ-
ity. Experiment C was conducted
to examine between-week varia-
tion of cTnT. Before breakfast at
8:30 AM, a blood sample was
collected. Between-week varia-
tion was calculated by using the
morning samples (8:30 AM) of experiments A through C. For
all subjects, experiments A through C were performed on the
same day of the week, within a total study period of 15 to
29 days.
Study 2: diurnal variation. After ﬁnalizing study 1, addi-
tional experiments were conducted to investigate the hy-
pothesis that circulating cTnT exhibits a diurnal rhythm.
Seven subjects who also participated in study 1 were sampled
every hour (8 ml) by using an antecubital venous catheter
over a time span of 25 h (Fig. 1). Participants were restricted
to a sedentary laboratory environment from 8:30 AM till
9:30 AM the next day with standardized meals consumed at
8:30 AM, 12:30 PM, and 5:00 PM (breakfast, lunch, and
dinner, respectively). Subjects went to bed at 11:30 PM, and
the lights were off at 11:35 PM until 7:00 AM. During the
night, polyethylene coiled extension lines (Vygon, Ecouen,
France) were used for blood sampling to prevent disturbance
of participants’ sleep.
Laboratory measurements. Blood samples were collected
in ethylenediaminetetraacetic acid–containing tubes. Imme-
diately upon collection, the blood samples were centrifuged,
and plasma was stored at –80C until analysis. Hematology
parameters were analyzed immediately in the diurnal samples
on a Sysmex XE-5000 analyzer (Sysmex Corporation, Kobe,
Japan). cTnT was measured in duplicate by using a high-
sensitivity cTnT assay (Roche Diagnostics, Indianapolis,
Indiana) on the cobas 6000 analyzer (lot number 167650).
The limits of blank and detection of the assay were 3 and
5 ng/l, respectively; the 99th percentile among healthy sub-
jects is 14 ng/l (13). Creatinine, creatine kinase (CK), and
albumin were measured on the cobas 6000 analyzer.
The estimated glomerular ﬁltration rate (eGFR) was calcu-
lated according to the Chronic Kidney Disease Epidemi-
ology Collaboration formula (14).
Statistical analysis. Between-person, within-person bio-
logical (CVi), and analytical coefﬁcients of variation were
calculated by using a balanced analysis of variance with a
nested random design in 2 levels; 95% conﬁdence intervals
Figure 1 Overview of Within-Day, Diurnal, and Between-Week Collection of Blood Samples
Within-day variation was estimated under sedentary (1A Sedentary) or habitual physical activity (1B Habitual physical activity) conditions in 23 patients over an 11-h period.
Between-week variation was estimated by using the 3 morning samples (8:30 AM) collected at the same day of the week within a total study period of 15 to 29 days (1A, 1B, and
1C morning sample only). Diurnal changes in cardiac troponin T were monitored in 7 subjects under sedentary conditions (2 Sedentary). Participants slept in supine position
between 11:30 PM and 7:00 AM (shaded area). All blood samples (indicated by arrows) were collected at standardized clock hours.
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1790(CIs) of these estimated variance components were
calculated according to the method of Burdick and
Graybill (15). Outliers in terms of the CVi were identiﬁed
by using Cochran’s C test. RCVs (z-score of 1.96) and the
index of individuality were calculated according to the
method of Fraser and Harris (16). RCVs were also eval-
uated after a log-normal transformation (17). The Wil-
coxon signed rank test was applied to compare cTnT
concentrations measured at 8:30 AM and 7:30 PM. He-
moglobin and hematocrit values were used to quantify
possible plasma volume changes due to changes in hy-
dration status and/or posture during the diurnal variation
study (18).Figure 2 Within-Day and Between-Week Distribution of Cardiac Trop
(A) Within-day distribution of cardiac troponin T (cTnT) (8:30 AM to 7:30 PM) in 23 subjects
23 subjects under standardized habitual physical activity. (C) Between-week distribution o
cTnT values from each sampling point for a given individual. The 99th percentile (14 ng/l) i
of cTnT concentration during the sedentary test day: generally, high subject numbers cor
extended to Figures 2B and 2C and Online Figure 1, allowing direct comparisons betweeDiurnal cTnT changes were analyzed by ﬁtting individual
data to a cosine curve with a 24-h period by using the
method of cosinor-rhythmometry as described by Nelson
et al. (19). Brieﬂy, the cosinor model is described as:
Z(t) ¼ M þ A$cos (ut þ 4) þ e(t), where Z(t) represents
the measured cTnT concentration at a given time (t), M
the mesor (average value of a cosine curve ﬁtted to the data),
A the amplitude (one-half the difference between the peak
and the nadir value), u the angular frequency (degrees per
unit time, with 360 representing a complete cycle), 4 the
acrophase (timing of maximal value in degrees), and e(t)
the error between the cosine model and the measurement.
Rearrangement of the model by using trigonometriconin T
under sedentary conditions. (B) Within-day distribution of cTnT (8:30 AM to 7:30 PM) in
f cTnT assessed by using the 3 morning samples (8:30 AM). Circles represent mean
s indicated by the dotted line. Subjects were ranked on the basis of their visual range
respond to a wider range in cTnT concentration. The ranking used for Figure 2A is
n ﬁgures throughout the paper.
Table 1 Within-Day and Between-Week Variation in Cardiac Troponin T Levels
Within-Day
Between-WeekSedentary Habitual Physical Activity
Samples/subjects 207/23 207/23 69/23
Mean concentration, ng/l 10.3 11.3 12.8
Variance components
CVG 38.4 (29.5–54.5) 40.4 (31.1–57.4) 43.8 (33.6–62.2)
CVi 14.2 (12.9–15.9) 12.7 (11.5–14.2) 9.7 (8.1–12.3)
CVA* 2.0 (1.8-2.2) 1.9 (1.8–2.1) 1.8 (1.5–2.1)
RCVy
Normal 39.8 35.7 27.4
Log-normal 48.6, –32.7 42.7, –29.9 31.4, –23.9
Index of individuality 0.37 0.32 0.23
Values are N/n, % (95% CI), or %. *On the basis of duplicate measurements. yOn the basis of a z-score of 1.96.
CI ¼ conﬁdence interval; CVA ¼ analytical coefﬁcient of variation; CVG ¼ between-person coefﬁcient of variation; CVi ¼ within-person biological
coefﬁcient of variation; RCV ¼ reference change value.
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1791identities produces a linear model in the coefﬁcients. Evi-
dence of a diurnal rhythm was indicated by a signiﬁcant
cosine model ﬁt (p < 0.05). A mean cosine model was
computed by using the rearranged cosine models in a linear
mixed model with a random subject term. All statistical
calculations were performed by using SPSS version 20 (IBM
SPSS Statistics, IBM Corporation, Armonk, New York).Results
Within-day biological variation of cTnT is larger than
between-week biological variation. The within-day dis-
tribution of cTnT (8:30 AM to 7:30 PM) in 23 subjects under
sedentary conditions is shown in Figure 2A. All values
(range 5.2 to 29.5 ng/l) were above the detection limit of the
assay, and 6 subjects had at least 1 measurement above the
99th percentile of 14 ng/l. To verify the results obtained
under completely sedentary conditions, the same subjects
were also measured during a second test day at a 1-week
interval that included habitual physical activity (see
Methods section). Results were highly comparable to the
sedentary test day: cTnT concentrations ranged from 5.4
to 31.2 ng/l, and 9 subjects had at least 1 measurement
above the 99th percentile (Fig. 2B). To estimate between-
week variability of cTnT, an additional morning sample
(8:30 AM) was collected at another 1-week interval. cTnT
concentrations at 8:30 AM on 3 separate visits were between
6.0 and 34.1 ng/l (Fig. 2C). Eight subjects had at least one
8:30 AM measurement above the 99th percentile.
Table 1 lists the within-day and between-week cTnT
variation components and their 95% CIs. The power of this
study to detect a CVi different from 0 was >0.8, taking
into account the number of subjects, samples, and replicates
and the observed ratio between the analytical variation
and the biological variation (20). Within-day biological
variability of cTnT was not affected by habitual physical
activity (CVi 14.2% [95% CI: 12.9% to 15.9%]) under
sedentary conditions compared with 12.7% (95% CI: 11.5%
to 14.2%) under habitual physical activity. Surprisingly, thewithin-day biological variation of cTnT under sedentary
conditions was signiﬁcantly higher than the between-week
variation, as indicated by nonoverlapping 95% CIs (CVi
14.2% [95% CI: 12.9% to 15.9%] vs. CVi 9.7% [95% CI:
8.1% to 12.3%]). A similar trend was present between
within-day biological variation of cTnT under habitual
physical activity and between-week biological variation.
Identiﬁcation and exclusion of subjects who were considered
outliers in terms of their within-person biological variation
provided similar results (data not shown). We further
examined the individual pattern of cTnT during the day to
gain additional insight in the relatively high within-day
biological variation of cTnT.
cTnT concentrations ﬂuctuate nonrandomly and exhibit
a gradual decrease during the day. cTnT concentrations
exhibited a gradual decrease during the sedentary test day,
with the highest concentration at 8:30 AM (median 11.8 ng/l
[interquartile range [IQR]: 9.3 to 15.2 ng/l) and the lowest
concentration at the end of the test day (7:30 PM; median 8.6
ng/l [IQR: 6.7 to 10.8 ng/l]; p < 0.001) (mean cTnT
decrease of 24%) (Fig. 3A). A similar decrease has been
previously reported for CK levels under constant resting
conditions, and this decrease could be reversed to stable
concentrations when light physical activity was introduced
during the day (21). To investigate whether the same
mechanism underlies the continuous decrease of cTnT, we
examined the cTnT pattern during the second test day,
which included 3 short walking sessions. Figure 3A shows
that the decline in cTnT was only marginally affected by the
3 walking sessions during the day: a median of 11.4 ng/l
(IQR: 9.2 to 16.7 ng/l) at 8:30 AM and a median of 9.8 ng/l
(IQR: 6.8 to 12.3 ng/l) at 7:30 PM (p < 0.001) (mean cTnT
decrease of 18%). In contrast, the gradually decreasing
pattern of CK observed under sedentary conditions was
completely reversed by habitual physical activity (Fig. 3B),
consistent with previous observations (21). The decreasing
pattern of cTnT was an evident phenomenon in all subjects,
and it was most prominent in subjects with the highest basal
cTnT levels (Fig. 3C, Online Fig. 1).
Figure 3 Cardiac troponin T Exhibits a Gradual Decrease During the Day, Which Is Not Affected by Habitual Physical Activity
(A) Cardiac troponin T (cTnT) change from baseline value under sedentary and habitual physical activity conditions (mean  SEM). (B) Creatine kinase (CK) change from
baseline value under sedentary conditions and habitual physical activity (mean  SEM). (C) Correlation between baseline cTnT value and magnitude of cTnT decrease under
sedentary conditions and habitual physical activity (Pearson’s R 0.93 and 0.91; both p < 0.001).
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function. To verify that the decreasing cTnT pattern was
not related to changes in kidney function or plasma volume,
we measured the concentrations of creatinine and albumin
during both test days. No time-of-day changes in eGFR
or albumin were observed under sedentary conditions or
habitual physical activity (Online Fig. 2).
Circulating cTnT exhibits a diurnal rhythm. To investi-
gate whether the decrease in cTnT during daytime was
followed by a rise during night hours, we collected blood
samples from 7 subjects every hour over a time span of 25 h
(from 8:30 AM to 9:30 AM the next day). In all participants,Figure 4 Cardiac Troponin T Exhibits a Diurnal Rhythm
(A) Individual 25-h cardiac troponin T (cTnT) proﬁles under sedentary conditions. Subjects s
subject (closed squares) was terminated at 10:30 PM due to technical problems with the
25-h cTnT proﬁle and ﬁtted cosine curve.the cTnT decline during daytime was accompanied by an
increase during night hours, with peak concentrations in the
morning (Fig. 4A). The intraindividual difference between
the peak and the nadir cTnT concentrations ranged from
3.4 to 11.8 ng/l. Correction for posture-induced changes in
plasma volume (18) did not abrogate the diurnal rhythm
(data not shown). Consistent with the sedentary test day,
CK values decreased continuously throughout the 25-h
period, whereas eGFR and albumin levels ﬂuctuated
randomly around the subject’s homeostatic set point (data
not shown). On the basis of this oscillation in cTnT, we
ﬁtted individual cTnT data to a cosine function to model thelept in a supine position between 11:30 PM and 7:00 AM (shaded area). Sampling in 1
intravenous cannula that hindered sampling throughout the night. (B) Mean  SEM
Table 2
The Individual Diurnal Variation of Cardiac Troponin T
Is Signiﬁcant, as Described by Using a Cosine Curve
Subject*
Mesor
(ng/l)
Amplitude
(ng/l)
Acrophase
(h) R2
: 19.5 4.1 9:08 AM 0.80y
; 21.7 2.3 9:18 AM 0.74y
-z 17.5 4.0 6:37 AM 0.91y
, 12.9 2.4 6:03 AM 0.81y
B 8.6 0.9 6:30 AM 0.65y
A 10.0 1.0 7:35 AM 0.55y
C 8.4 1.7 7:16 AM 0.63y
*Subject symbols correspond to the symbols used in Figure 4. yp < 0.001. zSample collection
until 10:30 PM (14 h).
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1793variation in the observed cTnT concentration as a function
of time. The ﬁtted cosine function for each individual can be
described by the mesor, amplitude, and acrophase (Table 2).
Quantitatively, in all participants, the diurnal cTnT variation
was signiﬁcantly described by the ﬁtted cosine curve, as
indicated by the “goodness-of-ﬁt” statistic (range R2 0.55 to
0.91; all p < 0.001). In line with the individual cTnT curves,
the group cosinor model exhibited a strong ﬁt with the mean
diurnal cTnT proﬁle (Fig. 4B).
Discussion
The present study provides novel evidence that circulating
cTnT levels exhibit a diurnal rhythm, characterized by peak
concentrations during morning hours, gradually decreasing
concentrations throughout daytime, and rising concentra-
tions during nighttime. This diurnal oscillation is a general
phenomenon but was most prominent in subjects with the
highest baseline cTnT values.
cTnT and type 2 diabetes. We studied biological vari-
ability of cTnT in patients with type 2 diabetes without acute
cardiovascular disease. Twenty percent of patients with type
2 diabetes have persistently elevated cTnT concentrations
above the 99th percentile, in the absence of an acute cardiac
event (22,23). Even in the pre-diabetic state (impaired
glucose tolerance or impaired fasting glucose), cTnT eleva-
tions are frequently observed (23). Type 2 diabetes is a highly
prevalent condition (25%) among patients who present at
the emergency department with symptoms suggestive of
AMI (5,24). A thorough understanding of the biological
variation of cTnT levels near or above the 99th percentile is
therefore a timely, and relatively unexplored, diagnostic issue.
Diurnal oscillation of cTnT: effect on reference change
values. The extended timeline and highly standardized
protocol for blood sampling formed the basis for the key
ﬁnding of this study: the presence of a diurnal rhythm of
cTnT. A remarkable consequence of the diurnal rhythm
is that the within-day biological variation was signiﬁcantly
higher than the between-week biological variation, provided
that the latter was measured in samples collected at the
same hour of the day. Another important consequence of
the diurnal rhythm relates to the violation of an importantpre-condition when using RCV; that is, the assumption
that biological variation is random. This point can be ill-
ustrated by using data from Figure 4. Under conditions of
nonrandom variation (e.g., a diurnal rhythm), the calculated
biological variation strongly depends on the time frame
chosen. For example, when a time frame between 8:30 AM
and 12:30 PM is considered, the calculated biological varia-
tion is more than twice the biological variation assessed in
the time frame between 4:30 PM and 8:30 PM (CVi 9.4%
[95% CI: 7.4% to 12.7%] vs. CVi 4.3% [95% CI: 3.1% to
6.2%], respectively). These differences translate directly to
changes of similar magnitude for RCV. The use of different
time frames across studies might have contributed to a
relatively broad range of biological variations in cTnT,
which have been previously assessed in healthy subjects and
patients with stable cardiovascular disease (8–11,25,26).
Altogether, the observation of a diurnal rhythm of cTnT,
with the highest amplitude in patients with the highest
baseline cTnT levels, may pose an additional challenge to
diagnosing AMI in this patient group.
Circadian variation in cardiovascular physiology and
pathology. The ﬁnding of a cardiac biomarker exhibiting
rhythmic activity is in line with the described circadian
variation in cardiovascular physiology, gene, and/or protein
expression (27). For example, heart rate and blood pressure
are lowest at nighttime and begin to rise before the time of
awakening in anticipation of the demands of daytime ac-
tivities, and they decrease again in the evening, anticipating
sleep (28). In addition, it has been shown that enhanced
amino acid incorporation into rat myocardial tissue takes
place during the sleeping hours, with the least synthesis
occurring 12 h later, indicating that myocardial growth and
renewal processes occur especially during the night (29). In
addition to physiology, cardiovascular pathology also ex-
hibits diurnal variation. For example, the incidence of AMI
displays a daily rhythmic pattern, with the highest inci-
dence between 6:00 AM and 12:00 PM (30,31). Even infarct
size exhibits a circadian dependence on the time-of-day
onset of ischemia, with the largest infarct sizes observed
in patients with symptom onset in the early morning hours
(32,33).
Biological signiﬁcance of a diurnal cTnT rhythm. The
biological signiﬁcance of a diurnal pattern in cTnT has yet
to be established. Related to this matter is elucidation of
the release mechanism of cTnT, as well as clearance from
the bloodstream. Similar to ﬁndings in the published data
(34), our eGFR ﬁndings were stable during the 25-h period,
indicating that the ﬂuctuations in cTnT could not be
explained by intraindividual changes in eGFR. However, it
is not clear if the ﬂuctuations reﬂect a disease-speciﬁc
mechanism (e.g., ischemia) or a physiological mechanism
(e.g., protein turnover). Nevertheless, these ﬁndings provide
support for the hypothesis that cTn can be applied to track
the impact of a number of physiological and pathophysio-
logical cardiovascular processes that are potentially unrelated
to cardiac ischemia (35,36). Therefore, it would be of
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1794interest to assess the rhythmicity of cTnT in healthy sub-
jects. These studies will become feasible when even more
sensitive assays become available, with higher precision in
the lower range.
Study limitations. Because the study group consisted of
overweight or obese type 2 diabetic patients treated with oral
glucose-lowering medication, we cannot generalize these
results directly to the cardio-healthy population. In addition,
various factors speciﬁc for the studied group might have
contributed to the diurnal rhythm of cTnT. The effect of
antidiabetic medication on cTnT levels is unknown,
although medication was stable for at least 3 months before
patient inclusion and was continued as normal during the
entire study period, including test days. We did not
explicitly control for intermittent low oxygen saturation
during the night (e.g., sleep apnea), which is often associated
with subjects who are overweight or obese. In addition, the
relationship between diurnal variation in heart rate and
blood pressure and cTnT levels has not been explored.
Finally, sample size, particularly for evaluation of diurnal
variation (n ¼ 7), was relatively low to exclude sample size
error. However, the validity of the data is supported by the
high consistency of the observations across all participants.
Conclusions
cTnT exhibited a diurnal rhythm in these study subjects
with increased odds of requiring hospital examination for
chest pain. The presence of a diurnal rhythm has direct
consequences for epidemiological studies and stresses the
necessity of interpreting all dynamic changes of cTnT in
relation to the clinical presentation. Although the ﬁnding of
a biomarker exhibiting circadian variation is in line with
cardiovascular physiology and pathology, further studies are
needed to understand the biological signiﬁcance and to
demonstrate the rhythmicity in various disease populations.
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